Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

1.

Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery.

Park JH, Cho HJ, Yoon HY, Yoon IS, Ko SH, Shim JS, Cho JH, Park JH, Kim K, Kwon IC, Kim DD.

J Control Release. 2014 Jan 28;174:98-108. doi: 10.1016/j.jconrel.2013.11.016. Epub 2013 Nov 23.

PMID:
24280260
[PubMed - indexed for MEDLINE]
2.

Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin.

Cho HJ, Yoon IS, Yoon HY, Koo H, Jin YJ, Ko SH, Shim JS, Kim K, Kwon IC, Kim DD.

Biomaterials. 2012 Feb;33(4):1190-200. doi: 10.1016/j.biomaterials.2011.10.064. Epub 2011 Nov 9.

PMID:
22074664
[PubMed - indexed for MEDLINE]
3.

Hyaluronic acid-ceramide-based optical/MR dual imaging nanoprobe for cancer diagnosis.

Cho HJ, Yoon HY, Koo H, Ko SH, Shim JS, Cho JH, Park JH, Kim K, Kwon IC, Kim DD.

J Control Release. 2012 Aug 20;162(1):111-8. doi: 10.1016/j.jconrel.2012.06.011. Epub 2012 Jun 15.

PMID:
22709587
[PubMed - indexed for MEDLINE]
4.

A novel cancer targeting approach based on estrone anchored stealth liposome for site-specific breast cancer therapy.

Paliwal SR, Paliwal R, Mishra N, Mehta A, Vyas SP.

Curr Cancer Drug Targets. 2010 May;10(3):343-53.

PMID:
20370682
[PubMed - indexed for MEDLINE]
5.

Hyaluronic acid derivative-based self-assembled nanoparticles for the treatment of melanoma.

Jin YJ, Termsarasab U, Ko SH, Shim JS, Chong S, Chung SJ, Shim CK, Cho HJ, Kim DD.

Pharm Res. 2012 Dec;29(12):3443-54. doi: 10.1007/s11095-012-0839-9. Epub 2012 Aug 11.

PMID:
22886625
[PubMed - indexed for MEDLINE]
6.

Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.

Han HS, Lee J, Kim HR, Chae SY, Kim M, Saravanakumar G, Yoon HY, You DG, Ko H, Kim K, Kwon IC, Park JC, Park JH.

J Control Release. 2013 Jun 10;168(2):105-14. doi: 10.1016/j.jconrel.2013.02.022. Epub 2013 Mar 6.

PMID:
23474029
[PubMed - indexed for MEDLINE]
7.

Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.

Jung SH, Jung SH, Seong H, Cho SH, Jeong KS, Shin BC.

Int J Pharm. 2009 Dec 1;382(1-2):254-61. doi: 10.1016/j.ijpharm.2009.08.002. Epub 2009 Aug 8.

PMID:
19666094
[PubMed - indexed for MEDLINE]
8.

Local targeted therapy of liver metastasis from colon cancer by galactosylated liposome encapsulated with doxorubicin.

Zhao C, Feng Q, Dou Z, Yuan W, Sui C, Zhang X, Xia G, Sun H, Ma J.

PLoS One. 2013 Sep 11;8(9):e73860. doi: 10.1371/journal.pone.0073860. eCollection 2013.

PMID:
24040096
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.

Eliaz RE, Szoka FC Jr.

Cancer Res. 2001 Mar 15;61(6):2592-601.

PMID:
11289136
[PubMed - indexed for MEDLINE]
Free Article
10.

Tumor targeting using anti-her2 immunoliposomes.

Park JW, Kirpotin DB, Hong K, Shalaby R, Shao Y, Nielsen UB, Marks JD, Papahadjopoulos D, Benz CC.

J Control Release. 2001 Jul 6;74(1-3):95-113.

PMID:
11489487
[PubMed - indexed for MEDLINE]
11.

Combined delivery and magnetic resonance imaging of neural cell adhesion molecule-targeted doxorubicin-containing liposomes in experimentally induced Kaposi's sarcoma.

Grange C, Geninatti-Crich S, Esposito G, Alberti D, Tei L, Bussolati B, Aime S, Camussi G.

Cancer Res. 2010 Mar 15;70(6):2180-90. doi: 10.1158/0008-5472.CAN-09-2821. Epub 2010 Mar 9.

PMID:
20215497
[PubMed - indexed for MEDLINE]
Free Article
12.

MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome.

Tagami T, Foltz WD, Ernsting MJ, Lee CM, Tannock IF, May JP, Li SD.

Biomaterials. 2011 Sep;32(27):6570-8. doi: 10.1016/j.biomaterials.2011.05.029. Epub 2011 Jun 8.

PMID:
21641639
[PubMed - indexed for MEDLINE]
13.

Assessing the in vivo efficacy of doxorubicin loaded hyaluronan nanoparticles.

El-Dakdouki MH, Xia J, Zhu DC, Kavunja H, Grieshaber J, O'Reilly S, McCormick JJ, Huang X.

ACS Appl Mater Interfaces. 2014 Jan 8;6(1):697-705. doi: 10.1021/am404946v. Epub 2013 Dec 12.

PMID:
24308364
[PubMed - indexed for MEDLINE]
14.

Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.

Gabizon A, Tzemach D, Gorin J, Mak L, Amitay Y, Shmeeda H, Zalipsky S.

Cancer Chemother Pharmacol. 2010 May;66(1):43-52. doi: 10.1007/s00280-009-1132-4. Epub 2009 Sep 25.

PMID:
19779718
[PubMed - indexed for MEDLINE]
15.

Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.

Paliwal SR, Paliwal R, Pal HC, Saxena AK, Sharma PR, Gupta PN, Agrawal GP, Vyas SP.

Mol Pharm. 2012 Jan 1;9(1):176-86. doi: 10.1021/mp200439z. Epub 2011 Nov 28.

PMID:
22091702
[PubMed - indexed for MEDLINE]
16.

Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU).

Park SM, Kim MS, Park SJ, Park ES, Choi KS, Kim YS, Kim HR.

J Control Release. 2013 Sep 28;170(3):373-9. doi: 10.1016/j.jconrel.2013.06.003. Epub 2013 Jun 13.

PMID:
23770213
[PubMed - indexed for MEDLINE]
17.

A simple way to enhance Doxil® therapy: drug release from liposomes at the tumor site by amphiphilic block copolymer.

Zhao Y, Alakhova DY, Kim JO, Bronich TK, Kabanov AV.

J Control Release. 2013 May 28;168(1):61-9. doi: 10.1016/j.jconrel.2013.02.026. Epub 2013 Mar 6.

PMID:
23474033
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Development of stealth liposome coencapsulating doxorubicin and fluoxetine.

Ong JC, Sun F, Chan E.

J Liposome Res. 2011 Dec;21(4):261-71. doi: 10.3109/08982104.2010.545070. Epub 2011 Jan 12.

PMID:
21226547
[PubMed - indexed for MEDLINE]
19.

[Targeting therapy of magnetic doxorubicin liposome in nude mice bearing colon cancer].

Zhou PH, Yao LQ, Qin XY, Shen XZ, Liu YS, Lu WY, Yao M.

Zhonghua Yi Xue Za Zhi. 2003 Dec 10;83(23):2073-6. Chinese.

PMID:
14703420
[PubMed - indexed for MEDLINE]
20.

Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.

Li L, ten Hagen TL, Hossann M, Süss R, van Rhoon GC, Eggermont AM, Haemmerich D, Koning GA.

J Control Release. 2013 Jun 10;168(2):142-50. doi: 10.1016/j.jconrel.2013.03.011. Epub 2013 Mar 21.

PMID:
23524188
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk